Peroxisome proliferator-activated receptor delta protects against obesity-related glomerulopathy through the P38 MAPK pathway

Obesity

Volumn 21, Issue 3, 2013, Pages 538-545

  Yan, Zhencheng ^a   Ni, Yinxing ^a   Wang, Peijian ^a   Chen, Jian ^a   He, Hongbo ^a   Sun, Jing ^a   Cao, Tingbing ^a   Chen, Jing ^a   Zhao, Zhigang ^a   Luo, Zhidan ^a   Chen, Lin ^b   Liu, Daoyan ^a   Zhu, Zhiming ^a  

^a Chongqing Institute of Cardiology   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BODY WEIGHT; CELL CULTURE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MATURATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME ACTIVATION; EXPRESSION VECTOR; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HISTOPATHOLOGY; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FUNCTION; LIPID DIET; MALE; MESANGIUM CELL; METABOLIC SYNDROME X; MICROALBUMINURIA; NONHUMAN; OBESITY; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RAT;

3T3-L1 CELLS; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; COLLAGEN; DIET, HIGH-FAT; GLOMERULAR MESANGIUM; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; LAMININ; MALE; MAP KINASE SIGNALING SYSTEM; MESANGIAL CELLS; METABOLIC SYNDROME X; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 14; OBESITY; PHOSPHORYLATION; PPAR DELTA; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 84876460403     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20103     Document Type: Article

References (40)

1. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD,. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498-1509.
2. Ma ST, Huang Y, Zhao ZG, et al. Activation of the cold-sensing TRPM8 channel triggers UCP1-dependent thermogenesis and prevents obesity. J Mol Cell Biol 2012; 4: 88-96.
3. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH,. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-1529.
4. Ribstein J, du Cailar G, Mimran A,. Combined renal effects of overweight and hypertension. Hypertension 1995; 26: 610-615.
5. Porter LE, Hollenberg NK,. Obesity, salt intake, and renal perfusion in healthy humans. Hypertension 1998; 32: 144-148.
6. Valensi P, Assayag M, Busby M, Paries J, Lormeau B, Attali JR,. Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord 1996; 20: 574-579.
7. Praga M, Morales E, Herrero JC, et al. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis 1999; 33: 52-58.
8. Adelman RD, Restaino IG, Alon US, Blowey DL,. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001; 138: 481-485.
9. Abrass CK,. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol 2004; 24: 46-53.
10. Ruan XZ, Zheng F, Guan YF,. PPARs and the kidney in metabolic syndrome. Am J Physiol Renal Physiol 2008; 294: F1032-F1047.
11. Ohga S, Shikata K, Yozai K, et al. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. Am J Physiol Renal Physiol 2007; 292: F1141-F1150.
12. Park CW, Zhang Y, Zhang X, et al. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Kidney Int 2006; 69: 1511-1517.
13. Takata Y, Liu J, Yin F, et al. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci U S A 2008; 105: 4277-4282.
14. Wang YX, Lee CH, Tiep S, et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003; 113: 159-170.
15. Coll T, Alvarez-Guardia D, Barroso E, et al. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells. Endocrinology 2010; 151: 1560-1569.
16. Letavernier E, Perez J, Joye E, et al. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. J Am Soc Nephrol 2005; 16: 2395-2402
17. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M,. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006; 55: 2502-2509.
18. Matsushita Y, Ogawa D, Wada J, et al. Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice. Diabetes 2011; 60: 960-968.
19. Ghosh SS, Gehr TW, Ghosh S, et al. PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase. Kidney Int 2003; 64: 52-62.
20. Chalkley SM, Hettiarachchi M, Chisholm DJ, Kraegen EW,. Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats. Am J Physiol Endocrinol Metab 2002; 282: E1231-E1238.
21. Yan ZC, Liu DY, Zhang LL, et al. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta. Biochem Biophys Res Commun 2007; 354: 427-433.
22. Kanetsuna Y, Hirano K, Nagata M, et al. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes. Am J Physiol Renal Physiol 2006; 291: F1315-F1322
23. Zhang LL, Liu DY, Ma LQ, et al. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ Res 2007; 100: 1063-1070.
24. Cheng L, Ding G, Qin Q, et al. Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochem Biophys Res Commun 2004; 313: 277-286.
25. Yang DC, Luo ZD, Ma ST, et al. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 2010; 12: 130-141.
26. Hao CM, Redha R, Morrow J, Breyer MD,. Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress. J Biol Chem 2002; 277: 21341-21345.
27. Komers R, Schutzer W, Xue H, Oyama TT, Lindsley JN, Anderson S,. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats. Transl Res 2007; 150: 343-349.
28. Lim AK, Nikolic-Paterson DJ, Ma FY, et al. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia 2009; 52: 347-358.
29. Liang YJ, Chen SA, Jian JH,. Peroxisome proliferator-activated receptor delta downregulates the expression of the receptor for advanced glycation end products and pro-inflammatory cytokines in the kidney of streptozotocin-induced diabetic mice. Eur J Pharm Sci 2011; 43: 65-70.
30. Lee SJ, Kang JG, Ryu OH, et al. Effects of alpha-lipoic acid on transforming growth factor beta1-p38 mitogen-activated protein kinase-fibronectin pathway in diabetic nephropathy. Metabolism 2009; 58: 616-623.
31. Bonventre JV, Force T,. Mitogen-activated protein kinases and transcriptional responses in renal injury and repair. Curr Opin Nephrol Hypertens 1998; 7: 425-433.
32. Rashed LA, Hashem RM, Soliman HM,. Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity. Biomed Pharmacother 2011; 65: 474-480.
33. Wang LX, Zeng JP, Wei XB, Wang FW, Liu ZP, Zhang XM,. Effects of scutellarin on apoptosis induced by cobalt chloride in PC12 cells. Chin J Physiol 2007; 50: 301-307.
34. Meissner M, Hrgovic I, Doll M, et al. Peroxisome proliferator-activated receptor {delta} activators induce IL-8 expression in nonstimulated endothelial cells in a transcriptional and posttranscriptional manner. J Biol Chem 2010; 285: 33797-33804.
35. Guan Y,. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. J Am Soc Nephrol 2004; 15: 2801-2815.
36. Chan W, Wang M, Martin RJ, Trachtman H, Hisano S, Chan JC,. mRNA expression for insulin-like growth factor 1, receptors of growth hormone and IGF-1 and transforming growth factor-beta in the kidney and liver of Zucker rats. Nutr Res 2001; 21: 1015-1023.
37. Berfield AK, Chait A, Oram JF, Zager RA, Johnson AC, Abrass CK,. IGF-1 induces rat glomerular mesangial cells to accumulate triglyceride. Am J Physiol Renal Physiol 2006; 290: F138-F147.
38. Zeng L, Geng Y, Tretiakova M, Yu X, Sicinski P, Kroll TG,. Peroxisome proliferator-activated receptor-delta induces cell proliferation by a cyclin E1-dependent mechanism and is up-regulated in thyroid tumors. Cancer Res 2008; 68: 6578-6586.
39. Jeong AY, Lee MY, Lee SH, Park JH, Han HJ,. PPARdelta agonist-mediated ROS stimulates mouse embryonic stem cell proliferation through cooperation of p38 MAPK and Wnt/beta-catenin. Cell Cycle 2009; 8: 611-619.
40. Clark J, Nasrallah R, Hebert RL,. The PPARdelta ligand GW501516 reduces growth but not apoptosis in mouse inner medullary collecting duct cells. PPAR Res 2009; 2009: 706283.